Management of catheter-related infection

Expert Review of Anti-Infective Therapy

Volumn 6, Issue 1, 2008, Pages 31-37

  Pagani, Jean Luc ^a   Eggimann, Philippe ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Antibiotic lock therapy; Bloodstream infection; Catheter related infection; Critical care; Guidewire exchange; Nosocomial infection

Indexed keywords

ALCOHOL; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; DOXYCYCLINE; EDETIC ACID; GENTAMICIN; HEPARIN; METICILLIN; MINOCYCLINE; MONOCLONAL ANTIBODY; STAPHYLOCOCCUS VACCINE; TAUROLIDINE; TEFIBAZUMAB; TEICOPLANIN; VANCOMYCIN;

ADJUVANT THERAPY; ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BLOOD CULTURE; CANDIDA; CANDIDIASIS; CATHETER INFECTION; CATHETER REMOVAL; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CRITICALLY ILL PATIENT; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FALSE NEGATIVE RESULT; FUNGAL STRAIN; GRAM NEGATIVE BACTERIUM; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INFECTION RISK; LABORATORY DIAGNOSIS; LOW DRUG DOSE; MORBIDITY; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; REVIEW; SEPSIS; STAPHYLOCOCCUS AUREUS; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VASCULAR ACCESS;

ANTI-BACTERIAL AGENTS; CATHETERIZATION; CATHETERIZATION, CENTRAL VENOUS; CROSS INFECTION; DISEASE MANAGEMENT; EQUIPMENT CONTAMINATION; HUMANS; INFECTION CONTROL;

EID: 40649123069     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.6.1.31     Document Type: Review

References (37)

1. Pratt RJ, Pellowe CM, Wilson JA et al. EPIC2: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J. Hosp. Infect. 65(Suppl. 1), S1-S64 (2007).
2. Higuera F, Rangel-Frausto MS, Rosenthal VD et al. Attributable cost and length of stay for patients with central venous catheter-associated bloodstream infection in Mexico City intensive cam units: a prospective, matched analysis. Infect. Control Hosp. Epidemiol. 28(1), 31-35 (2007).
3. Pronovost P, Needham D, Berenholtz S et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N. Engl. J. Med. 355(26), 2725-2732 (2006).
4. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin. Proc. 81(9), 1159-1171 (2006).
5. O'Grady NP, Alexander M, Dellinger EP et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. Morb. Mortal. Wkly Rep. 51(RR-10), 1-29 (2002).
6. National Nosocomial Infections Surveillance (NNIS) System Report. Data summary from January 1992 through June 2004, issued October 2004. Am. J. Infect. Control 32(8), 470-485 (2004).
7. Eggimann P. Diagnosis of intravascular catheter infection. Curr. Opin. Infect. Dis. 20(4), 353-359 (2007).
8. Eggimann P, Pittet D. Infection control in the ICU. Chest 120(6), 2059-2093 (2001).
9. Wenzel RP, Edmond MB. Team-based prevention of catheter-related infections. N. Engl. J. Med. 355(26), 2781-2783 (2006).
10. Eggimann P. Prevention of intravascular catheter infection. Curr. Opin. Infect. Dis. 20(4), 360-369 (2007).
11. Mermel LA, Farr BM, Sherertz RI, et. al. Guidelines for the management of intravascular catheter-related infections. Clin. Infect. Dis. 32(9), 1249-1272 (2001).
12. Worthington T, Elliott TS. Diagnosis of central venous catheter related infection in adult patients. J. Infect. 51(4), 267-280 (2005).
13. Donlan RM, Costerton JW. Bioforms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15(2), 167-193 (2002).
14. Giacometti A, Cirioni O, Ghiselli R et al. Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. Antimicrob. Agents Chemother. 49(10), 4042-4045 (2005).
15. Bouza E, Alvarado N, Alcala L, Perez MJ, Rincon C, Munoz P. A randomized and prospective study of 3 procedures for the diagnosis of catheter-related bloodstream infection without catheter withdrawal. Clin. Infect. Dis. 44(6). 820-826 (2007).
16. Linares J. Diagnosis of catheter-related bloodstream infection: conservative techniques. Clin. Infect. Dis. 44(6) 827-829 (2007).
17. Calandra T, Cohen J. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit. Care Med. 33(7), 1588-1548 (2005).
18. Warren DK, Quadir WW, Hollenbeak CS, Elward AM, Cox MJ, Fraser VJ. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit. Care Med. 34(8), 2084-2089 (2006).
19. Lorente L, Jimenez A, Iribarren JL, Jimenez JJ, Martin MM, Mora ML. The micro-organism responsible for central venous catheter related bloodstream infection depends on catheter site. Intensive Care Med. 32(9), 1449-1450 (2006).
20. Pottecher T, Gauzit R. [Should we use catheter replacement with the aid of wire introducer?]. Ann. Fr. Anesth. Reanim. 24(3), 294-297 (2005).
21. Timsit JF. [Updating of the 12th Consensus Conference of the Societe de Reanimation de Langue Francaise (SRLF): catheter related infections in the intensive care unit]. Ann. Fr. Anesth. Reanim. 24(3), 315-322 (2005).
22. Rosen AB, Fowler VG Jr, Corey GR et al. Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia. Ann. Intern. Med. 130(10), 810-820 (1999).
23. Fowler VG Jr, Li J, Corey GR et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J. Am. Coll. Cardiol. 30(4), 1072-1078 (1997).
24. Abraham J, Mansour C, Veledar E, Khan B, Lerakis S. Staphylococcus aureus bacteremia and endocarditis: the Grady Memorial Hospital experience with methicillin-sensitive S aureus and methicillin-resistant S aureus bacteremia. Am. Heart J. 147(3), 536-539 (2004).
25. Weems JJ Jr, Steinberg JP, Filler S et al. Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia. Antimicrob. Agents Chemother. 50(8), 2751-2755 (2006).
26. Mermel LA. New technologies to prevent intravascular catheter-related bloodstream infections. Emerg. Infect. Dis. 7(2), 197-199 (2001).
27. Rex JH, Walsh TJ, Sobel JD et al. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin. Infect. Dis. 30(4), 662-678 (2000).
28. Nucci M, Anaissie E. Should vascular catheters be removed from all patients with candidemia? An evidence-based review. Clin. Infect. Dis. 34(5), 591-599 (2002).
29. van de Wetering, van Woensel JB. Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients. Cochrane Database Syst. Rev. 1, CD003295 (2007).
30. Segarra-Newnham M, Martin-Cooper EM. Antibiotic lock technique: a review of the literature. Ann. Pharmacother. 39(2), 311-318 (2005).
31. Safdar N, Maki DG. Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. Clin. Infect. Dis. 43(4), 474-484 (2006).
32. Feely T, Copley A, Bleyer AJ. Catheter lock solutions to prevent bloodstream infections in high-risk hemodialysis patients. Am. J. Nephrol. 27(1), 24-29 (2007).
33. Chiou PF, Chang CC, Wen YK, Yang Y. Antibiotic lock technique reduces the incidence of temporary catheter-related infections. Clin. Nephrol. 65(6). 419-422 (2006).
34. Opilla MT, Kirby DF, Edmond MB. Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients. J. Parenter. Enteral. Nutr. 31(4), 302-305 (2007).
35. Onland W, Shin CE, Fustar S, Rushing T, Wong WY. Ethanol-lock technique for persistent bacteremia of long-term intravascular devices in pediatric patients. Arch. Pediatr. Adolesc. Med. 160(10), 1049-1053 (2006).
36. Percival SL, Kite P, Eastwood K et al. Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect. Control Hosp. Epidemiol. 26(6), 515-519 (2005).
37. Raad I, Hanna H, Maki D. Intravascular catheter-realted infections: advances in diagnosis, prevention, and management. Lancet Infect. Dis. 7, 645-647 (2007).